Welcome to our dedicated page for Phreesia news (Ticker: PHR), a resource for investors and traders seeking the latest updates and insights on Phreesia stock.
Phreesia reports developments tied to its patient activation platform for healthcare providers, life sciences companies and other organizations. The company’s recurring news includes quarterly results, stakeholder letters, patient intake, outreach, education and appointment-scheduling solutions, and the scale of patient visits enabled through its digital workflows.
Company updates also cover healthcare payment capabilities, including the completed AccessOne acquisition, credit-facility refinancing, and corporate governance or workplace recognition items. Phreesia’s news flow is centered on software, payments and engagement tools used across healthcare delivery and patient interactions.
Phreesia (NYSE: PHR) will release fiscal first quarter 2027 results after market close on Wednesday, May 27, 2026. A press release and a quarterly stakeholder letter will be posted at the company investor website, followed by a live conference call and webcast at 5:00 PM ET.
Dial (833) 461-5787 or (626) 884-3620 (international) with conference code 953036497. A replay will be available on the same investor page for approximately 90 days. Phreesia reported enabling more than 180 million patient visits in 2025.
Phreesia (NYSE: PHR) was named to Becker’s Hospital Review’s 2026 list of “Revenue Cycle Management Companies to Know” on April 14, 2026. The recognition highlights Phreesia’s patient intake, payment and workflow tools that digitize intake, centralize payment processing and aim to improve collections and reduce manual work.
MediFind (NASDAQ: PHR) announced it received the DiMe Seal from the Digital Medicine Society on April 9, 2026, becoming the first doctor directory awarded this independent digital health trust mark. DiMe evaluates platforms on clinical evidence, privacy and security, and usability.
Phreesia acquired MediFind in July 2023. The seal aims to help consumers identify higher‑trust digital health tools when searching for specialists, including rare disease care.
Phreesia (NYSE: PHR) reported fiscal 2026 results with revenue of $480.6M (up 14% YoY), GAAP net income of $2.3M, Adjusted EBITDA $101.5M, and free cash flow of $54.4M. Q4 revenue was $127.1M (+16% YoY) and Q4 Adjusted EBITDA was $29.4M.
The company completed the AccessOne acquisition for ~$164M and refinanced debt with a new five-year $275M Capital One facility. Phreesia lowered fiscal 2027 revenue guidance to $510M–$520M but maintained Adjusted EBITDA guidance of $125M–$135M.
Phreesia (NYSE: PHR) was named one of Becker’s Healthcare Top Places to Work in Healthcare 2026, marking its second appearance on the list. As an all‑remote employer, Phreesia highlights competitive pay, flexible time off, home‑office support, parental benefits and professional development programs.
The company reported enabling approximately 170 million patient visits in 2024, and emphasizes employee resource groups, wellness programs and connection as part of its people strategy.
Phreesia (NYSE:PHR) and Sesame Workshop won the Point of Care Excellence Award at POCMA’s POC Now Summit on March 18, 2026 for their pediatric health and wellness campaign.
The partners launched a six-part campaign in October 2025 after announcing a five-year collaboration in August 2025. Early metrics show 64% of parents found the Sesame Street content very helpful and 91% said it was easy to understand.
Phreesia (NYSE: PHR) entered a new senior secured revolving credit facility of up to $275 million with Capital One as agent and borrowed approximately $92.2 million at closing to repay and terminate its prior bridge loan without penalty.
The new facility replaces a prior $50 million asset-based revolver and can be used for working capital, capex, permitted acquisitions and general corporate purposes; the company said the refinancing reduces borrowing costs and improves financial flexibility.
Phreesia (NYSE: PHR) announced that Tiffany McGee, assistant general counsel, commercial contracts, was named to The Software Report’s 2025 Top Women Leaders in Software list on March 12, 2026. This marks the eighth consecutive year a Phreesia woman has been included.
McGee negotiates complex commercial agreements, led Phreesia’s shift to fully digital contracting to shorten deal cycles and improve close rates, brings over 18 years of legal experience, and mentors colleagues through the company’s mentorship program.
Phreesia (NYSE:PHR) was named to the 2026 Capterra Shortlist for Appointment Scheduling, an independent recognition based on user ratings and popularity signals. Phreesia previously made four Capterra Shortlists in 2025, and holds a 4.3/5 rating from 166 reviews on Capterra.
This acknowledgment highlights customer feedback on Phreesia's patient intake, outreach, and scheduling tools and underscores the product's visibility and user satisfaction in software search data.
Phreesia (NYSE: PHR) announced that Tara Sheehy, Senior Director of Client Experience for Phreesia Network Solutions, was named to the MM+M Women to Watch class of 2026. Sheehy oversees more than 20 major accounts and leads an 18-person team, credited with driving new business growth, account expansion and consistent client retention.
Colleagues highlighted her mentorship, leadership during rapid growth, and contributions to client experience and healthcare marketing.